Patterns in outpatient benzodiazepine prescribing in the United States. | AHRQ Patient Safety Network

Patterns in outpatient benzodiazepine prescribing in the United States. | AHRQ Patient Safety Network

• Study
 
• Published February 2019

Patterns in outpatient benzodiazepine prescribing in the United States.

Agarwal SD, Landon BE. JAMA Netw Open. 2019;2:e187399.

This observational study based on surveillance data documents increasing rates of benzodiazepine prescribing in outpatient care over time. The rate of coprescription of benzodiazepines with opioids and other sedating medications has also increased, raising concerns for harm including overdose deaths and hospitalizations.

PubMed citationFree full textRelated news article

Related Resources

JOURNAL ARTICLE › COMMENTARY

Our other prescription drug problem.

Lembke A, Papac J, Humphreys K. N Engl J Med. 2018;378:693-695.

JOURNAL ARTICLE › STUDY

Safer prescribing—a trial of education, informatics, and financial incentives.

Dreischulte T, Donnan P, Grant A, Hapca A, McCowan C, Guthrie B. N Engl J Med. 2016;374:1053-1064.

NEWSPAPER/MAGAZINE ARTICLE

Remote CPOE error—a situation that's more than remotely possible.

ISMP Medication Safety Alert! Acute Care Edition. May 31, 2007;12:1-3.

JOURNAL ARTICLE › STUDY

Adherence to black box warnings for prescription medications in outpatients.

Lasser KE, Seger DL, Yu DT, et al. Arch Intern Med. 2006;166:338-344.

JOURNAL ARTICLE › STUDY

Avoiding chemotherapy prescribing errors: analysis and innovative strategies.

Reinhardt H, Otte P, Eggleton AG, et al. Cancer. 2019 Jan 29; [Epub ahead of print].

View More